Related Experiment Video

Updated: Aug 13, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency

Keping Xie1, Suyun Huang

  • 1Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA. kepxie@mail.mdanderson.org

Free Radical Biology & Medicine
|April 10, 2003
PubMed

Insights

Nitric oxide (NO) plays a dual role in cancer metastasis. While high levels can induce tumor cell death, low levels may promote resistance and tumor progression, highlighting NO

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis is an inefficient process where most tumor cells die.
  • Tumor-host interactions during metastasis generate nitric oxide (NO).
  • NO's role in tumor cell survival and metastasis is complex and multifactorial.

Purpose of the Study:

  • To investigate the intricate role of nitric oxide (NO) in regulating tumor cell survival during metastasis.
  • To explore how nitric oxide synthase II (NOS II) expression impacts tumor cell fate and metastatic potential.

Main Methods:

  • Analysis of nitric oxide (NO) production in the context of tumor cell dissemination.
  • Evaluation of inducible nitric oxide synthase II (NOS II) expression in tumor progression.
  • Assessment of tumor cell resistance to NO and its implications for metastasis.

Main Results:

  • NO's effect on tumor cell survival depends on production levels and tumor cell genetics.
  • Inducible nitric oxide synthase II (NOS II) can produce cytotoxic levels of NO, inducing apoptosis.
  • Impaired NOS II expression may lead to NO resistance, promoting tumor progression and metastasis.

Conclusions:

  • Restoring NOS II expression and overcoming NO resistance are potential strategies to inhibit tumor growth and metastasis.
  • Targeting NO pathways could offer novel therapeutic approaches for managing metastatic cancer.
  • Understanding NO's dual role is crucial for developing effective anti-metastasis treatments.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...